| Nirav Paresh Chiniwalla, MD | |
|
1070 Vinehaven Dr, Concord, NC 28025-2438 | |
| (704) 783-1840 | |
| (704) 783-1850 |
| Full Name | Nirav Paresh Chiniwalla |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 25 Years |
| Location | 1070 Vinehaven Dr, Concord, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114955291 | NPI | - | NPPES |
| 142H3 | Other | NC | BLUE CROSS BLUE SHIELD |
| 5904428 | Medicaid | NC | |
| P00346657 | Other | NC | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carolinas Medical Center-northeast | Concord, NC | Hospital |
| Novant Health Rowan Medical Center | Salisbury, NC | Hospital |
| Stanly Regional Medical Center | Albemarle, NC | Hospital |
| Carolinas Medical Center/behav Health | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cabarrus Gastroenterology Associates Pllc | 9436059649 | 34 |
News Archive
Scientists at Dana-Farber Cancer Institute have discovered a molecular switch that enables advanced prostate cancers to spread without stimulation by male hormones, which normally are needed to spur the cancer's growth. They say the finding could lead to a new treatment for prostate cancers that are no longer controlled by hormone-blocking drugs.
LSTM is to lead a new multinational project on sepsis following a £2 million award from the National Institute of Health Research.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced the launch of a new high-resolution, high-throughput pre-implantation genetic screening (PGS) microarray aimed at improving embryo screening for in vitro fertilisation (IVF). The CytoSure™ Embryo Screen Array offers eight arrays of 60,000 spots for high-resolution genome-wide aneuploidy and copy number detection in pre-implantation embryos.
Halyard Health, Inc. today reported second quarter 2015 results and updated its net sales and adjusted diluted earnings per share outlook for full-year 2015.
› Verified 8 days ago
| Entity Name | Cabarrus Gastroenterology Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780790592 PECOS PAC ID: 9436059649 Enrollment ID: O20040113000342 |
News Archive
Scientists at Dana-Farber Cancer Institute have discovered a molecular switch that enables advanced prostate cancers to spread without stimulation by male hormones, which normally are needed to spur the cancer's growth. They say the finding could lead to a new treatment for prostate cancers that are no longer controlled by hormone-blocking drugs.
LSTM is to lead a new multinational project on sepsis following a £2 million award from the National Institute of Health Research.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced the launch of a new high-resolution, high-throughput pre-implantation genetic screening (PGS) microarray aimed at improving embryo screening for in vitro fertilisation (IVF). The CytoSure™ Embryo Screen Array offers eight arrays of 60,000 spots for high-resolution genome-wide aneuploidy and copy number detection in pre-implantation embryos.
Halyard Health, Inc. today reported second quarter 2015 results and updated its net sales and adjusted diluted earnings per share outlook for full-year 2015.
› Verified 8 days ago
| Entity Name | Carolinas Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437607686 PECOS PAC ID: 3375449655 Enrollment ID: O20040115000819 |
News Archive
Scientists at Dana-Farber Cancer Institute have discovered a molecular switch that enables advanced prostate cancers to spread without stimulation by male hormones, which normally are needed to spur the cancer's growth. They say the finding could lead to a new treatment for prostate cancers that are no longer controlled by hormone-blocking drugs.
LSTM is to lead a new multinational project on sepsis following a £2 million award from the National Institute of Health Research.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced the launch of a new high-resolution, high-throughput pre-implantation genetic screening (PGS) microarray aimed at improving embryo screening for in vitro fertilisation (IVF). The CytoSure™ Embryo Screen Array offers eight arrays of 60,000 spots for high-resolution genome-wide aneuploidy and copy number detection in pre-implantation embryos.
Halyard Health, Inc. today reported second quarter 2015 results and updated its net sales and adjusted diluted earnings per share outlook for full-year 2015.
› Verified 8 days ago
| Entity Name | The Charlotte-mecklenburg Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669738829 PECOS PAC ID: 2961310685 Enrollment ID: O20100309000605 |
News Archive
Scientists at Dana-Farber Cancer Institute have discovered a molecular switch that enables advanced prostate cancers to spread without stimulation by male hormones, which normally are needed to spur the cancer's growth. They say the finding could lead to a new treatment for prostate cancers that are no longer controlled by hormone-blocking drugs.
LSTM is to lead a new multinational project on sepsis following a £2 million award from the National Institute of Health Research.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced the launch of a new high-resolution, high-throughput pre-implantation genetic screening (PGS) microarray aimed at improving embryo screening for in vitro fertilisation (IVF). The CytoSure™ Embryo Screen Array offers eight arrays of 60,000 spots for high-resolution genome-wide aneuploidy and copy number detection in pre-implantation embryos.
Halyard Health, Inc. today reported second quarter 2015 results and updated its net sales and adjusted diluted earnings per share outlook for full-year 2015.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nirav Paresh Chiniwalla, MD 1070 Vinehaven Dr, Concord, NC 28025-2438 Ph: (704) 783-1840 | Nirav Paresh Chiniwalla, MD 1070 Vinehaven Dr, Concord, NC 28025-2438 Ph: (704) 783-1840 |
News Archive
Scientists at Dana-Farber Cancer Institute have discovered a molecular switch that enables advanced prostate cancers to spread without stimulation by male hormones, which normally are needed to spur the cancer's growth. They say the finding could lead to a new treatment for prostate cancers that are no longer controlled by hormone-blocking drugs.
LSTM is to lead a new multinational project on sepsis following a £2 million award from the National Institute of Health Research.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced the launch of a new high-resolution, high-throughput pre-implantation genetic screening (PGS) microarray aimed at improving embryo screening for in vitro fertilisation (IVF). The CytoSure™ Embryo Screen Array offers eight arrays of 60,000 spots for high-resolution genome-wide aneuploidy and copy number detection in pre-implantation embryos.
Halyard Health, Inc. today reported second quarter 2015 results and updated its net sales and adjusted diluted earnings per share outlook for full-year 2015.
› Verified 8 days ago
Dr. Vinay Patel, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1070 Vinehaven Dr Ne, Concord, NC 28025 Phone: 704-783-1840 Fax: 704-783-1850 | |
Aishwarya Palwai, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 920 Church St N, Concord, NC 28025 Phone: 704-403-1311 | |
Meghan Rebecca Steiner, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Park Dr, Ste 110, Concord, NC 28025 Phone: 704-403-1370 | |
Ashley Noisette Green, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 200 Medical Park Dr, Ste 330, Concord, NC 28025 Phone: 704-403-1308 | |
Stephen Sean Zouzoulas, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Park Dr, Ste 210, Concord, NC 28025 Phone: 704-403-6100 | |
Dr. Ernest F Johnson Iii, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 433 Copperfield Blvd Ne, Concord, NC 28025 Phone: 704-786-7770 Fax: 704-971-0035 | |
Thomas Cary Cameron, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1085 Ne Gateway Ct Ne, Ste 330, Concord, NC 28025 Phone: 704-403-8320 |